15 December 2015 - Deborah Wilkes
Archived
Australia's Therapeutic Goods Administration (TGA) is consulting on a broader range of options for codeine-containing medicines. The move comes soon after the regulatory agency deferred a decision on its proposed reverse-switch of all non-prescription medicines containing codeine to prescription status.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.